Role of nuclear medicine in cancer care: From timely diagnosis, detection of potential relapses, to better treatment planning

"Nuclear medicine has been available in India for the last 50 years. Whereas, PRRT therapies got US FDA approval last year," says Dr Sameer Sonar, Fellow, Harvard Medical School, USA, Group Director – Nuclear Medicine, PET CT Theranostics,Ruby Hall Clinic Group Hospitals

Related Keywords

India ,Mumbai ,Maharashtra ,United States ,Australia ,Karuna Luthra ,G Vamshi Krishna Reddy ,Kokilaben Dhirubhai Ambani ,Atomic Energy Regulatory Board ,Oncology Services ,India Institute Of Medical Sciences ,Bhabha Atomic Research Centre ,Nuclear Medicine ,Ruby Hall Clinic Group Hospitals ,Harvard Medical School ,Director Oncology Services ,Consultant Medical Oncologist ,Anshu Sharma Consultant ,Dhirubhai Ambani Hospital Mumbai ,Positron Emission Tomography ,Prostate Cancer ,Thyroid Cancer ,Neuroendocrine Cancers ,Foundation Hospital ,Sameer Sonar ,Group Director ,All India Institute ,Cancer Treatment ,Chemotherapy ,Sa ,Radiopharmaceuticals ,Get Scan ,Radioimmunotherapy ,Targeted Therapy ,Radiation Therapy ,Monitoring Treatment Response ,Uclear Medicine For Cancer India Vs Usa ,Adiopharmaceuticals For Cancer Treatment India And Usa ,Et Scan And Cancer Diagnosis India Vs Usa ,Argeted Therapy For Cancer Nuclear Medicine Vs Chemotherapy ,Uclear Medicine Advantages For Cancer Treatment ,